InMed Pharmaceuticals Inc. (INM) Financials
INM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.0 million | 2.0 million |
| March 31, 2026 | 9.1 million | 2.2 million |
| Dec. 31, 2025 | 15.4 million | 2.2 million |
| Sept. 30, 2025 | 18.6 million | 2.5 million |
INM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.9 million | 132.0 million |
| March 31, 2026 | -1.8 million | 38771 |
| Dec. 31, 2025 | -3.2 million | 45.4 million |
| Sept. 30, 2025 | -2.2 million | 20205 |
INM Net Income
No data available :(
INM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.2 million | - | - |
| March 31, 2026 | 5.2 million | - | 30766 |
| Dec. 31, 2025 | 9.6 million | - | 730082 |
| Sept. 30, 2025 | 13.0 million | - | 892965 |
INM Shares Outstanding
INM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 5 | 567.9 million | 1.9 billion | - |
| March 31, 2026 | 4 | 1.0 million | 1.7 million | - |
| Dec. 31, 2025 | 5 | 865314 | 2.1 million | - |
| Sept. 30, 2025 | - | 581612 | 1.5 million | - |
INM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 2.1 billion | 1.8 billion |
| March 31, 2026 | 659.8 million | 134656 |
| Dec. 31, 2025 | 1.1 million | 1.1 million |
| Sept. 30, 2025 | 1.1 million | 716962 |
INM
Price: $1.38
52 week price:
Earnings Per Share: -2.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 53653
Market Capitalization: 7.3 million